Newbury Park, CA, United States of America

John J Sullivan

This inventor holds 1 USPTO granted patent. Top assignees: Amgen Inc., Medarex Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John J Sullivan. Retrieved from https://idiyas.com/inventor/john-j-sullivan-urc1el21

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John J Sullivan

Introduction

John J Sullivan is a notable inventor based in Newbury Park, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work has implications for treating osteopenic disorders, showcasing the intersection of innovation and healthcare.

Latest Patents

Sullivan holds a patent for "Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors." This patent includes monoclonal antibodies and hybridomas that interact with osteoprotegerin ligand (OPGL). The methods outlined in the patent provide ways to treat osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL. Additionally, the patent describes methods for detecting the amount of OPGL in a sample using these antibodies.

Career Highlights

Throughout his career, John J Sullivan has worked with prominent companies in the biotechnology sector. He has been associated with Amgen Inc. and Medarex Inc., where he contributed to various innovative projects. His expertise in antibody development has positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include William James Boyle and Eugene Medlock. Their collaborative efforts have further advanced the research and development of therapeutic antibodies.

Conclusion

John J Sullivan's contributions to biotechnology, particularly through his patent on OPGL neutralizing antibodies, highlight his role as an innovator in the field. His work continues to influence the treatment of osteopenic disorders and showcases the importance of collaboration in scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…